ArticleJournal of vascular surgery. Venous and lymphatic disorders2026
Stenting for symptomatic left renal vein compression in patients with complex pelvic venous disease is safe on long-term follow-up.
Article in Journal of vascular surgery. Venous and lymphatic disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The continuing challenge of Nutcracker syndrome.Journal of vascular surgery. Venous and lymphatic disorders · 2026Article
- Percutaneous left renal vein stenting in posterior nutcracker syndrome: technical and antithrombotic nuances - a case report.Frontiers in cardiovascular medicine · 2026Article
- Left Ovarian Vein Transposition to Restore Renal Venous Outflow in a Patient With Severe Pelvic Congestion After Multiple Endovascular and Failed Open Procedures for Nutcracker Syndrome.EJVES vascular forum · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe ideal treatment for symptomatic left renal vein (LRV) compression continues to be debated, with several available open and endovascular options. Concerns about percutaneous stenting have been raised due to risk of stent migration, fracture, and erosion. This study aims to assess the long-term safety, patency, and effectiveness of LRV stenting.
methodsA retrospective institutional chart review of all patients undergoing LRV stenting for symptomatic LRV compression between 2010 and 2024 was conducted. Baseline characteristics, operative details, complications, reinterventions, and symptom resolution were collected. Complete resolution was defined as full relief of presenting symptoms; partial resolution as patient-reported improvement without full relief; and no relief as no change from preoperative symptoms.
resultsA total of 44 patients were identified. Forty-three patients with complete follow-up were included in the analysis. A total of 13 patients underwent LRV transposition for symptomatic compression at our institution in the same time frame; of which six required stenting due to symptom recurrence and were included in the analysis. The mean age was 42.6 years (range, 17.6-79.1 years). Body mass index ranged from 15.2 to 42.5 kg/m
conclusionsLRV stenting for symptomatic compression offers a minimally invasive approach and results in high symptom resolution and patency with no major stent complications at long-term follow-up. It can continue to be a treatment option where appropriate expertise is available.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.